首页> 美国卫生研究院文献>Biochemistry and Biophysics Reports >Establishment of X-linked Alport syndrome model mice with a Col4a5 R471X mutation
【2h】

Establishment of X-linked Alport syndrome model mice with a Col4a5 R471X mutation

机译:具有Col4a5 R471X突变的X连锁Alport综合征模型小鼠的建立

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Alport syndrome (AS) is an inherited disorder characterized by glomerular basement membrane (GBM) abnormality and development of chronic kidney disease at an early age. The cause of AS is a genetic mutation in type IV collagen, and more than 80% of patients have X-linked AS (XLAS) with mutation in COL4A5. Although the causal gene has been identified, mechanisms of progression have not been elucidated, and no effective treatment has been developed. In this study, we generated a Col4a5 mutant mouse harboring a nonsense mutation (R471X) obtained from a patient with XLAS using clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated system. Col4a5 mRNA and protein expressions were not observed in the kidneys of hemizygous R471X male mice. R471X mice showed proteinuria and hematuria. Pathology revealed progression of glomerulosclerosis and interstitial fibrosis by age. Electron microscopy identified irregular thickening in GBM accompanied by irregular lamination. These observations were consistent with the clinical and pathological features of patients with AS and other established models. In addition, our mice models develop end-stage renal disease at the median age of 28 weeks, much later compared to previous models much more consistent with clinical course of human XLAS. Our models have advantages for future experiments in regard with treatment for human XLAS.
机译:Alport综合征(AS)是一种遗传性疾病,其特征是肾小球基底膜(GBM)异常以及在早期就患有慢性肾脏疾病。 AS的病因是IV型胶原蛋白的遗传突变,超过80%的患者患有X连锁AS(XLAS),其COL4A5突变。尽管已经确定了病因基因,但尚未阐明其进展机制,也未开发出有效的治疗方法。在这项研究中,我们产生了一个Col4a5突变小鼠,该小鼠带有无义突变(R471X),该突变小鼠使用簇状规则间隔的短回文重复(CRISPR)/ CRISPR相关系统从XLAS患者获得。在半合R471X雄性小鼠的肾脏中未观察到Col4a5 mRNA和蛋白表达。 R471X小鼠显示蛋白尿和血尿。病理显示,随着年龄的增长,肾小球硬化和间质纤维化进展。电子显微镜检查发现GBM中出现不规则的增厚,并伴有不规则的层压。这些观察结果与AS患者和其他已建立模型的临床和病理特征一致。此外,我们的小鼠模型在中位年龄为28周时发展为终末期肾脏疾病,与以前的模型相比,其发生时间要晚得多,与人类XLAS的临床病程更加一致。对于人类XLAS的治疗,我们的模型在以后的实验中具有优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号